Scientists have discovered a critical part of the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
Professor Graham Lord, from The University of Manchester, led the study, which could translate into treatments for autoimmune diseases including Cancer, Diabetes, Multiple Sclerosis and Crohn’s Disease within a few years.
It is published in The Journal of Clinical Investigation today.
The discovery of the molecular pathway regulated by a tiny molecule – known as microRNA-142 – is a major advance in our understanding of the immune system.
The 10-year-study found that microRNA-142 controls Regulatory T cells, which modulate the immune system and prevent autoimmune disease. It is, they found, the most highly expressed regulator in the immune system.
Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering. But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit
Professor Graham Lord
And according to Professor Lord, the discovery could be translated into a viable drug treatment within a few years.
He said: “Autoimmune diseases often target people in the prime of their life creating a significant socio-economic burden on them. Sometimes, the effect can be devastating, causing terrible hardship and suffering.
“But these findings represent a significant step forward in the understanding of the immune system and we believe many people worldwide may benefit.”
If the activity of Regulatory T cells is too low, this can cause other immune cells to attack our own body tissues. If these Regulatory T cells are too active, this leads to suppression of immune responses and can allow cancers to evade the immune system.
So being able to control them is a major step forward in our ability to control- and harness – the therapeutic power of the immune system.
Professor Richard Jenner from UCL, who led the computational side of the project, said that: “We were able to trace the molecular fingerprints of this molecule across other genes to determine how it acted as such a critical regulator.”
Professor Lord, now Vice President and Dean of the Faculty of Biology, Medicine and Health at The University of Manchester, added: “Scientists over the past decade or so have developed therapies which are able to modulate different pathways of the immune system. We hope that this new discovery will lead to the development of new ways to treat autoimmunity, infectious diseases and cancer and we are incredibly excited about where this may lead.”
The Latest on: Autoimmune diseases
[google_news title=”” keyword=”autoimmune diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Autoimmune diseases
- COVID patient's strange symptoms save her from deadly undiagnosed diseases. Here's what doctors discovered.on April 26, 2024 at 5:33 pm
Vicky Dennis had COVID in 2020 and went to the hospital with strange symptoms. Doctors found she had two undiagnosed, life-threatening diseases and that she needed a liver transplant to survive.
- Anti-Inflammatory Use May Reduce PD Risk in Patients With Autoimmune Diseaseson April 26, 2024 at 6:33 am
Researchers examined the relationship between exposure to anti-inflammatory therapy and the incidence of Parkinson disease in patients with autoimmune conditions.
- What It’s Like to Live With Neurologic Lyme Disease: A Patient Perspectiveon April 26, 2024 at 6:24 am
Diagnosing patients with neurologic Lyme disease can take upwards of 2 years, which Maria Arini Lopez discovered first-hand in the spring of 2021.
- Yoga practices to follow to manage autoimmune disorderson April 25, 2024 at 8:30 pm
Yoga helps manage autoimmune conditions by promoting relaxation, reducing inflammation, and supporting well-being. Techniques include gentle poses, de ...
- Fever, swollen glands, fatigue, rash and joint pain? Know how to identify autoimmune diseaseson April 25, 2024 at 6:45 pm
What complicates matters is that symptoms may overlap with other diseases and triggers may be unknown, says internal medicine expert Dr Suranjit Chatterjee ...
- Patients of autoimmune liver disease treated with immune suppressants have lower prevalence of apical periodontitis: Studyon April 24, 2024 at 6:30 am
Patients of autoimmune liver disease treated with immune suppressants have a lower prevalence of apical periodontitis suggests a study published in the Journal of Endodontics.Autoimmune ...
- Wiregrass teen battling cancer and rare kidney disease passes awayon April 22, 2024 at 4:46 pm
A Wiregrass teen, who for the past year has been battling cancer and a rare kidney disease, has passed away. Anna Oyler is a recent graduate of Harvest Christian School and last year was diagnosed ...
- Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meetingon April 22, 2024 at 3:30 pm
Key Therapeutic Mechanisms of Clinical Activity for Autoimmune Diseases, including B cell Depletion, Tissue Infiltration and Immune ...
- How myeloid cell replacement could help treat autoimmune encephalomyelitison April 19, 2024 at 5:40 am
Autoimmune conditions such as multiple sclerosis (MS) are disorders of the immune system associated in this case with demyelination of the central nervous system (CNS). The term demyelination ...
- Cullinan Targets Autoimmune Market, Nabs $280M in Private Placementon April 17, 2024 at 5:00 am
Cullinan Oncology, now renamed Cullinan Therapeutics, is riding the growing wave of interest in autoimmune disorders by refocusing its bispecific T cell-engager CLN-978 for systemic lupus ...
via Bing News